These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 13735416)

  • 1. ["Comparative study of several drugs belonging to the group of the 1,2-diphenyl-3,5-diketopyrazolidines. I."].
    PICCININI F; MARAZZI-UBERTI E; LUGARESI C
    Arch Int Pharmacodyn Ther; 1961 Jun; 132():16-28. PubMed ID: 13735416
    [No Abstract]   [Full Text] [Related]  

  • 2. [Comparative study of several drugs of the series of 1,2-diphenyl-3,5-diketopyrazolidines. II].
    PICCININI F
    Arch Int Pharmacodyn Ther; 1961 Jun; 132():29-41. PubMed ID: 13735419
    [No Abstract]   [Full Text] [Related]  

  • 3. [On an iodinated derivative of 1,2-diphenyl-4-n-butyl-3,5-pyrazolidinedione].
    CONTI L
    Farmaco Prat; 1961 May; 16():240-3. PubMed ID: 13695183
    [No Abstract]   [Full Text] [Related]  

  • 4. [About the glucoside of 1,2-diphenyl-3,5-dioxo-4-n-butyl-pyrazolidine (phenylbutazone)].
    MOREL CJ
    Experientia; 1958 Aug; 14(8):294-5. PubMed ID: 13574145
    [No Abstract]   [Full Text] [Related]  

  • 5. [Comparative toxicity of various phenylbutazone derivatives].
    DEROUAUX G; OLEFFE-KOOPMANSCH S
    C R Seances Soc Biol Fil; 1961; 155():1419-20. PubMed ID: 13885610
    [No Abstract]   [Full Text] [Related]  

  • 6. A double-blind comparison of phenylbutazone and suxibuzone, a prodrug of phenylbutazone, in rheumatoid arthritis.
    Mizushima Y; Shiokawa Y; Honma M; Kageyama T
    Int J Tissue React; 1983; 5(1):35-9. PubMed ID: 6345427
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Comparative studies on the bioavailability of various drug forms of phenylbutazone and clofezone (Perclusone)].
    Reinicke C; Helbing M; Klingenfeld U; Lasaroff I; Wessel G
    Pharmazie; 1984 Dec; 39(12):824-7. PubMed ID: 6241720
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Some derivatives of 1,2-diphenyl-4-butyl-3, 5-pirazolidine-dione. II].
    FRANCHI G
    Farmaco Sci; 1956; 11(10):819-22. PubMed ID: 13414852
    [No Abstract]   [Full Text] [Related]  

  • 9. [Pharmacological properties of 1,2-diphenyl-4-(gamma-ketobutyl)-pyrazolidine-3,5-dione].
    HORAKOVA Z; NEMECEK O; PUJMAN V; MAYER J; CTVRTNIK J; VOTAVA Z
    Arzneimittelforschung; 1958 Apr; 8(4):229-31. PubMed ID: 13535357
    [No Abstract]   [Full Text] [Related]  

  • 10. [Toxicity and kinetics of the elimination of 4-butyl-2-phenyl-3, 5-pyrazolidinedione compared with that of the 1,2-diphenyl derivative].
    SCARSELLI V
    Farmaco Sci; 1959; 14(5):347-51. PubMed ID: 13663921
    [No Abstract]   [Full Text] [Related]  

  • 11. A new pyrazolidine derivative - benetazone spofa - in short- and medium-term treatment of rheumatoid arthritis. (Double-blind comparative study with phenylbutazone).
    Pavelka K; Vojtisek O; Bremová A; Kauková D; Hándlová D
    Int J Clin Pharmacol Biopharm; 1976 Jul; 14(1):20-8. PubMed ID: 61951
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical result of the treatment of chronic rheumatoid arthritis by non-steroidal anti-inflammatory agent, clofezone. Comparative study with phenylbutazone in a double-blid study at several clinics].
    Kageyama T
    Ryumachi; 1976 Mar; 16(1):85-99. PubMed ID: 135360
    [No Abstract]   [Full Text] [Related]  

  • 13. [Pharmacological properties of the metabolites of 1,2-diphenyl-3,5-dioxo-4-n-butylpyrazolidine].
    WILHELMI G
    Arzneimittelforschung; 1960 Feb; 10():129-33. PubMed ID: 13855379
    [No Abstract]   [Full Text] [Related]  

  • 14. [Toxicity and antiphlogistic effects of 4-(3-chloro-3-buteny1)-1,2-diphenyl-3,5-pyrazolidinedione].
    LENFELD J; KROUTIL M; BOCEK M; CTVRTNIK J; MAYER J
    Arzneimittelforschung; 1961 Apr; 11():427-9. PubMed ID: 13760809
    [No Abstract]   [Full Text] [Related]  

  • 15. Phenylbutazone and its derivatives with special reference to G.27202.
    HART FD; BURLEY D
    Br Med J; 1959 Apr; 1(5129):1087-9. PubMed ID: 13638638
    [No Abstract]   [Full Text] [Related]  

  • 16. [New antiphlogistic drugs: G-27202].
    TREZZINI C
    Clin Ter; 1962 Jul; 23():57-63. PubMed ID: 13922446
    [No Abstract]   [Full Text] [Related]  

  • 17. [4-prenyl-1,2-diphenyl-3,5-pyrazolidindione (DA 2370) in rheumatoid arthritis: clinical study with the use of a new weighted articular index].
    Cerri B; Bianchi G; Chierichetti S
    Reumatismo; 1972; 24(3):217-24. PubMed ID: 4549698
    [No Abstract]   [Full Text] [Related]  

  • 18. [On the use and antiphlogistic therapeutic effectiveness of a metabolite of phenylbutazone in some disease processes of otorhinolaryngoiatric interest].
    PAROLARI P
    Otorinolaringol Ital; 1961 Dec; 30():462-6. PubMed ID: 14484015
    [No Abstract]   [Full Text] [Related]  

  • 19. [Diffractometric study of pyrazinobutazone and related compounds].
    Toussaint J; Vermeire M
    Ann Pharm Fr; 1974 Jun; 32(6):383-90. PubMed ID: 4433140
    [No Abstract]   [Full Text] [Related]  

  • 20. [Clinico-metabolic actoin of some phenylbutazone derivatives (G 27202, G 28315 and keto-phenylbutazone)].
    CIRLA E; RATTI G
    Reumatismo; 1960; 12():76-80. PubMed ID: 13693726
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.